Adenosine Injection, 6mg/2mL (3mg/mL) Vial
- Product NDC
- 51662-1201
- 11-digit product format
- 516621201
- Labeler code
- 51662
- Product ID
- 51662-1201_a8230f20-c325-8fd3-e053-2a95a90a147a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Adenosine Injection, 6mg/2mL (3mg/mL) Vial
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- HF Acquisition Co. LLC, DBA Health First
- Application
- ANDA078076
- Marketing category
- ANDA
- Marketing start
- 2018-07-14
- Marketing end
- 0000-00-00
- Substance
- ADENOSINE
- Active strength
- 3 mg/mL
- Pharmacologic classes
- Adenosine Receptor Agonist [EPC],Adenosine Receptor Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51662-1201-1 | Adenosine Injection, 6mg/2mL (3mg/mL) Vial | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | | 8 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51662-1201 | ADENOSINE INJECTION, 6MG/2ML (3MG/ML) VIAL INJECTION, SOLUTION [HF ACQUISITION CO. LLC, DBA HEALTH FIRST] | 8 | Legacy NDC, 1 package rows | 20231011_68f36fc8-8f10-593f-e053-2991aa0a48de.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51662-1201-1 | 51662120101 | 2 mL in 1 VIAL (51662-1201-1) | 2 ml | 2018-07-14 | 0000-00-00 | No | No | Current |
| 51662-1201-3 | 51662120103 | 20 POUCH in 1 CASE (51662-1201-3) > 1 mL in 1 POUCH (51662-1201-2) | 20 pouch | 2020-06-15 | 0000-00-00 | No | No | Current |